CUZ reports Q1 2026 results today with options positioning at its most defensive in months — even as the stock has staged a sharp recovery.
The put/call ratio has climbed to 1.04, well above its 20-day average of 0.63 and roughly 1.5 standard deviations elevated. That makes the current reading among the highest of the past year for this ticker. The caution is notable given the stock's trajectory: CUZ has rallied 17% over the past month to $25.06, clawing back a significant portion of earlier losses. Yet despite that recovery, options traders are adding more protective puts than calls — a tension worth watching as the earnings number lands.
Short interest is a meaningful part of the picture here. At 8.4% of the free float, it represents a real short base, and the position has grown roughly 7% over the past month. Days to cover have climbed to 7.5 by FINRA's most recent fortnightly report. That said, the borrow market is far from stressed. Availability remains loose — a cost to borrow of just 0.58%, up 32% on the week but still at near-baseline levels in absolute terms, signals no squeeze pressure. Shorts appear to be adding exposure into the print rather than being forced out.
The bull-bear debate centres on Sunbelt office fundamentals. Bulls point to CUZ's Sunbelt concentration — markets where population and job growth have supported leasing momentum — and a revised FFO estimate that factors in a recent Dallas acquisition. Bears focus on a projected occupancy decline, with a major Bank of America moveout expected to drag the portfolio rate from 90% toward 89% by year-end, set against broader macro headwinds including slower national job growth and the lingering structural shift toward remote work. The analyst consensus reflects this ambivalence: multiple firms including Evercore ISI, BMO Capital, Barclays, and Truist all trimmed price targets in recent months while largely holding positive or neutral ratings, leaving the mean target at $28.83 against a current price of $25.06 — roughly 15% upside on paper, but with the target itself trending downward.
Institutional ownership is dominated by the usual passive giants — Vanguard and BlackRock together hold nearly 30% — but Alyeska Investment Group added close to 3.9 million shares as of December, a notable active position build. At the executive level, six members of senior management including the CEO and CFO all sold shares on the same day in February, a cluster sale that followed award grants earlier that month; the trades were modest in value but the synchronised timing is worth noting as the team prepares to speak to the market.
The print today tests whether leasing activity and FFO guidance can justify CUZ's 17% recovery — or whether the occupancy overhang and analyst target compression make that bounce harder to sustain.
See the live data behind this article on ORTEX.
Open CUZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
